MDWerks, Inc. (MDWK): Letter to Shareholders A Message About Our Reporting Status

MDWerks, Inc. (MDWK) filed an SEC Form 8-K — Regulation FD Disclosure. Exhibit 99.1 Letter to Shareholders A Message About Our Reporting Status MDWerks, Inc. (OTC: MDWK) | November 16, 2026 Dear Fellow Shareholders, Today MDWerks, Inc. filed a Form 15 with the Securities and Exchange Commission to deregister our common stock and suspend our SEC repo

Original reporting
Published Nov 16, 2026, 9:48 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 16, 2026, 11:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$MDWK
Bearish
medium confidence
Mentioned
$MDWK
Relevance
8/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$MDWKBearishMed
01

Why it matters

The key trade implication is reduced SEC filing cadence and format, which can change valuation models, widen bid-ask spreads, and increase uncertainty around financial updates.

02

Market read

For MDWK traders, the disclosure regime changes from SEC filings to OTC Alternative Reporting, with explicit warnings about liquidity and restricted-share resale.

03

What to watch

The letter says MDWK intends to remain quoted on OTC Markets Pink and continue publishing annual and quarterly information, which may partially offset the loss of SEC filings.

Relevance 8/10Novelty 8/10Timing: after-hours filing on Nov. 16, 2026, with disclosure shift effective immediately

Background

The company’s 8-K Item 7.01 furnishes a shareholder letter explaining its decision to file Form 15 and deregister from SEC reporting.

Company-level read

Ticker impact

$MDWKBearishMedium confidence
Context

MDWerks filed a Form 15 to deregister its common stock and stop SEC reporting, shifting disclosures to OTC Markets’ alternative standard.

Expected impact

Likely downward pressure or higher volatility as investors price in reduced disclosure and potential liquidity risk.

Evidence & confidence

The filing is a primary corporate reporting-status change, and the letter explicitly warns trading liquidity and restricted-share resale may be affected.

Market effects

Highlights ongoing cost-cutting and reporting-status risk for small OTC issuers, which can affect sentiment toward similar microcaps.

Limited, primarily impacts US OTC market participants trading MDWK.

Low, this is a company-specific US OTC reporting change.

Counterpoint

If OTC Alternative Reporting Standard disclosures remain timely and investors adapt, the impact could be muted versus fears of information blackout.

Key entities

  • MDWerks, Inc.

    OTC-listed issuer that filed Form 15 to deregister and suspend SEC reporting obligations.

  • OTC Markets

    Platform the company says it will use for alternative reporting disclosures.

  • SEC Form 15

    Filing used to deregister securities and suspend SEC reporting obligations.

Related articles

$SPGIMed

S&P Global prices $2 billion senior notes offering

S&P Global (SPGI) priced a $2 billion senior notes offering in three tranches, with yields ranging from 5.635% to 6.001%. The notes are due 2031, 2034, and 2036, and proceeds will be used for general corporate purposes. The offering is expected to close around November 18, 2026, and is managed by several major financial institutions. The notes will be unsecured obligations of the company, guaranteed by a subsidiary.

$SPGIMed

S&P Global Announces Pricing of Public Offering of $750,000,000 Senior Notes due 2031, $600,000,000 Senior Notes due 2034 and $650,000,000 Senior Notes due 2036

S&P Global (NYSE: SPGI) priced a public offering of $750M, $600M, and $650M in senior notes due 2031, 2034, and 2036, respectively. The notes were priced at yields of 5.635%, 5.814%, and 6.001%. Proceeds will be used for general corporate purposes, including possible acquisitions or debt repayment. The offering is expected to close on November 18, 2026, subject to conditions.